本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MBX Biosciences

59.31
+0.29000.49%
成交量:2.05萬
成交額:122.06萬
市值:28.56億
市盈率:-24.66
高:59.91
開:59.35
低:58.93
收:59.02
52周最高:72.64
52周最低:9.63
股本:4,816.01萬
流通股本:2,762.99萬
量比:0.77
換手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
淨資產收益率:-33.17%
總資產收益率:-22.08%
市淨率:6.97
市盈率(LYR):-24.90

資料載入中...

2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities